AI MARKET SCANNING

Belite Bio, Inc

🏛️ NASDAQ 📁 Healthcare 🏭 Biotechnology
AVG HISTORICAL GAP -0.43%
MAX GAP RECORD -4.32%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $BLTE
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 13, 2026 Earnings Release 2026-08-13 (BEFORE OPEN)
+0.00%
May 20, 2026 Earnings Release 2026-05-20 (BEFORE OPEN)
+1.66%
Mar 02, 2026 Earnings Release 2026-03-02 (BEFORE OPEN)
-0.82%
Nov 10, 2025 Earnings Release 2025-11-10 (BEFORE OPEN)
+0.85%
Aug 11, 2025 Earnings Release 2025-08-11 (BEFORE OPEN)
-1.27%
May 14, 2025 Earnings Release 2025-05-14 (BEFORE OPEN)
+0.00%
Mar 17, 2025 Earnings Release 2025-03-17 (BEFORE OPEN)
-2.72%
Nov 12, 2024 Earnings Release 2024-11-12 (BEFORE OPEN)
-0.42%

VOLATILITY & GAP BIAS

AVG GAP MOVE 1.6%
Bullish Gaps (3)
Bearish Gaps (4)
Neutral / Flat (5)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $BLTE

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics with unmet medical needs in the United States. Its lead product candidate is Tinlarebant (LBS-008), an orally administered, which is in phase 3 clinical trial as an early intervention for maintaining…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗